Focus on the Melatonin Metabolite N1-Acetyl-5-methoxykynuramine (AMK)

Rüdiger Hardeland
Additional contact information
Rüdiger Hardeland: University of Goettingen, Goettingen

Biomedical Journal of Scientific & Technical Research, 2017, vol. 1, issue 3, 849-853

Abstract: The melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK) is a bioactive compound that acts as a potent inhibitor of cyclooxygenases, of neuronal NO synthase and myeloperoxidase, as a downregulator of cycloxygenase-2 and inducible NO synthase...

Keywords: Biomedical Sciences; Biomedical Research; Technical Research; AMK; Inflammation; NO synthases; Posttranslational modification; RNS; ROS (search for similar items in EconPapers)
Date: 2017
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.000318.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.000318.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:1:y:2017:i:3:p:849-853

DOI: 10.26717/BJSTR.2017.01.000318

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().